CASPer Practice Test 2025 – Your All-in-One Guide to Excel in Computer-Based Assessment for Sampling Personal Characteristics

In this scenario, informing the patient that it is a placebo is important because transparency is essential for maintaining trust and ethical standards in the patient-provider relationship. When a patient insists on using a placebo, it highlights their belief in its effectiveness, which often stems from their personal experiences or a desire for relief. However, using a placebo without the patient's awareness can undermine their autonomy and right to make informed decisions about their health.

By choosing to inform the patient that what they are using is a placebo, you respect their right to be involved in their treatment options. This option promotes open communication, allowing for a discussion about the potential benefits and limitations of placebo use versus evidence-based treatments. It also opens the door to exploring their preferences and any underlying concerns they may have about alternatives that have proven efficacy.

The other options do not prioritize patient autonomy or informed consent. Continuing the placebo without informing the patient could lead to ethical dilemmas later. Switching to an evidence-based treatment without addressing the patient's preferences may also lead to resistance or dissatisfaction with care. Ignoring the patient's choice altogether disregards their input and could damage the therapeutic relationship. Therefore, informing the patient about the nature of the placebo is the most appropriate and ethically sound approach.